---
title: Improving 10-year cardiovascular risk prediction in patients with type 2 diabetes
  with metabolomics
date: '2025-01-13'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39806417/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250114170947&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: Incorporating seven metabolomic biomarkers in the SCORE2-Diabetes
  model enhanced its ability to predict MACE in patients with type 2 diabetes. Given
  the latest cost reduction and standardization efforts, NMR metabolomics has the
  potential for translation into the clinical ...'
disable_comments: true
---
CONCLUSIONS: Incorporating seven metabolomic biomarkers in the SCORE2-Diabetes model enhanced its ability to predict MACE in patients with type 2 diabetes. Given the latest cost reduction and standardization efforts, NMR metabolomics has the potential for translation into the clinical ...